MedTrace Logo

Stereotactic Radiosurgery in Treating Patients With Brain Metastases

NCT00811655 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2013-11-25

Study results available
· View outcomes & findings →

Summary

RATIONALE: Stereotactic radiosurgery may be able to send x-rays directly to the tumor and cause less damage to normal tissue. Giving stereotactic radiosurgery before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed.

PURPOSE: This phase II trial is studying how well stereotactic radiosurgery works in treating patients with brain metastases.

Conditions

Interventions

PROCEDURE

therapeutic conventional surgery

Surgery of a single brain metastasis.

RADIATION

stereotactic radiosurgery

Pre-operative single fraction SRS

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Duke University

    lead OTHER

Principal Investigators

  • John H. Sampson, MD, PhD · Duke University

  • Hamidreza Aliabadi, MD · Duke University

  • John P. Kirkpatrick, MD · Duke University

  • James E. Herndon, PhD · Duke University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2010-08-31
Completion
2010-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00811655 on ClinicalTrials.gov